Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol etabonate for ocular surface inflammation in dry eye
NL-OMON26452Active, not recruiting
- Sponsor
- University of Genoa
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of loteprednol etabonate in dry eye syndrome (DED) (2 arms), sponsored by University of Genoa. Primary endpoint: Change in conjunctival HLA-DR expression. Started Jan 2010; status: active, not recruiting.
02
Drugs
loteprednol etabonate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NL-OMON26452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26452.